217 related articles for article (PubMed ID: 11996479)
21. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.
Mikesch JH; Kuhlmann M; Demant A; Krug U; Thoennissen GB; Schmidt E; Kessler T; Schliemann C; Pohlen M; Mohr M; Evers G; Köhler G; Wessling J; Mesters R; Müller-Tidow C; Berdel WE; Thoennissen NH
Ann Hematol; 2013 Aug; 92(8):1041-8. PubMed ID: 23532626
[TBL] [Abstract][Full Text] [Related]
22. [Complete remission of a highly malignant, progressive under therapy Wilm's tumor using the combination carboplatin and etoposide (VP 16)].
Walka MM; Schröter W; Lakomek M
Monatsschr Kinderheilkd; 1991 Dec; 139(12):836-40. PubMed ID: 1663216
[TBL] [Abstract][Full Text] [Related]
23. Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital.
Campbell AD; Cohn SL; Reynolds M; Seshadri R; Morgan E; Geissler G; Rademaker A; Marymount M; Kalapurakal J; Haut PR; Duerst R; Kletzel M
J Clin Oncol; 2004 Jul; 22(14):2885-90. PubMed ID: 15254057
[TBL] [Abstract][Full Text] [Related]
24. Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.
Daw NC; Gregornik D; Rodman J; Marina N; Wu J; Kun LE; Jenkins JJ; McPherson V; Wilimas J; Jones DP
Eur J Cancer; 2009 Jan; 45(1):99-106. PubMed ID: 18996004
[TBL] [Abstract][Full Text] [Related]
25. A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Griffin TC; Weitzman S; Weinstein H; Chang M; Cairo M; Hutchison R; Shiramizu B; Wiley J; Woods D; Barnich M; Gross TG;
Pediatr Blood Cancer; 2009 Feb; 52(2):177-81. PubMed ID: 18816698
[TBL] [Abstract][Full Text] [Related]
26. Retrospective analysis of bevacizumab in combination with ifosfamide, carboplatin, and etoposide in patients with second recurrence of glioblastoma.
Arakawa Y; Mizowaki T; Murata D; Fujimoto K; Kikuchi T; Kunieda T; Takahashi JC; Takagi Y; Miyamoto S
Neurol Med Chir (Tokyo); 2013; 53(11):779-85. PubMed ID: 24140770
[TBL] [Abstract][Full Text] [Related]
27. Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Itoh K; Igarashi T; Ohtsu T; Wakita H; Watanabe Y; Fujii H; Minami H; Sasaki Y
Int J Hematol; 1998 Dec; 68(4):431-7. PubMed ID: 9885442
[TBL] [Abstract][Full Text] [Related]
28. [Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)].
Hirota T; Takeuchi M; Iwata A; Kitagawa S; Sato T; Konno K; Sawada K; Kobayashi S; Hamaguchi N; Agata H; Katano N; Fujimoto T
Gan To Kagaku Ryoho; 1998 Feb; 25(3):385-90. PubMed ID: 9492832
[TBL] [Abstract][Full Text] [Related]
29. Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.
Kushner BH; Modak S; Kramer K; Basu EM; Roberts SS; Cheung NK
Cancer; 2013 Feb; 119(3):665-71. PubMed ID: 22951749
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer.
Lee HS; Lee YG; Koo DH; Oh S; Nam H; Song JU; Lim SY; Lim SY; Lee SS
Cancer Chemother Pharmacol; 2015 Nov; 76(5):933-7. PubMed ID: 26374553
[TBL] [Abstract][Full Text] [Related]
31. A novel trial of topotecan, ifosfamide, and carboplatin (TIC) in children with recurrent solid tumors.
Radhakrishnan K; Lee A; Harrison LA; Morris E; Shen V; Gates L; Wells RJ; Wolff JE; Garvin JH; Cairo MS
Pediatr Blood Cancer; 2015 Feb; 62(2):274-278. PubMed ID: 25382188
[TBL] [Abstract][Full Text] [Related]
32. Acute pancreatitis induced by ifosfamide therapy.
Garg R; Agarwala S; Bhatnagar V
J Pediatr Surg; 2010 Oct; 45(10):2071-3. PubMed ID: 20920734
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of ifosfamide in the treatment of relapses in Wilms' tumor.
Tournade MF
Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S31-3. PubMed ID: 2547529
[TBL] [Abstract][Full Text] [Related]
34. Phase II study of carboplatin as a single drug for relapsed Wilms' tumor: experience of the Brazilian Wilms' Tumor Study Group.
de Camargo B; Melaragno R; Saba e Silva N; Mendonça N; Alvares MN; Morinaka E; Marques A; Cusato MP
Med Pediatr Oncol; 1994; 22(4):258-60. PubMed ID: 8107657
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group.
Malogolowkin M; Cotton CA; Green DM; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D;
Pediatr Blood Cancer; 2008 Feb; 50(2):236-41. PubMed ID: 17539021
[TBL] [Abstract][Full Text] [Related]
36. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Wenger M; Lange W; Mertelsmann R
Ann Oncol; 1997 Jan; 8(1):49-56. PubMed ID: 9093707
[TBL] [Abstract][Full Text] [Related]
37. Results of novel strategies for treatment of Wilms' tumor.
Tucci S; Cologna AJ; Suaid HJ; Valera ET; Tirapelli LF; Paschoalin EL; Martins AC
Int Braz J Urol; 2007; 33(2):195-201; discussion 201-3. PubMed ID: 17488540
[TBL] [Abstract][Full Text] [Related]
38. Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study.
Sanson M; Ameri A; Monjour A; Sahmoud T; Ronchin P; Poisson M; Delattre JY
Eur J Cancer; 1996 Dec; 32A(13):2229-35. PubMed ID: 9038603
[TBL] [Abstract][Full Text] [Related]
39. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
Siegert W; Beyer J; Strohscheer I; Baurmann H; Oettle H; Zingsem J; Zimmermann R; Bokemeyer C; Schmoll HJ; Huhn D
J Clin Oncol; 1994 Jun; 12(6):1223-31. PubMed ID: 7911158
[TBL] [Abstract][Full Text] [Related]
40. High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
Kleiner S; Kirsch A; Schwaner I; Kingreen D; Schwella N; Huhn D; Siegert W
Bone Marrow Transplant; 1997 Dec; 20(11):953-9. PubMed ID: 9422474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
